 | Up a level |
Journal Article
Kontoyiannis, Dimitrios P., Selleslag, Dominik, Mullane, Kathleen, Cornely, Oliver A., Hope, William 
ORCID: 0000-0001-6187-878X, Lortholary, Olivier, Croos-Dabrera, Rodney, Lademacher, Christopher, Engelhardt, Marc and Patterson, Thomas F.
(2018).
Impact of unresolved neutropenia in patients with neutropenia and invasive aspergillosis: a post hoc analysis of the SECURE trial.
J. Antimicrob. Chemother., 73 (3).
S. 757 - 764.
OXFORD:
OXFORD UNIV PRESS.
ISSN 1460-2091
Maertens, Johan A., Raad, Issam I., Marr, Kieren A., Patterson, Thomas F., Kontoyiannis, Dimitrios P., Cornely, Oliver A., Bow, Eric J., Rahav, Galia, Neofytos, Dionysios ORCID: 0000-0001-6970-2869, Aoun, Mickael, Baddley, John W., Giladi, Michael, Heinz, Werner J., Herbrecht, Raoul ORCID: 0000-0002-9381-4876, Hope, William ORCID: 0000-0001-6187-878X, Karthaus, Meinolf, Lee, Dong-Gun ORCID: 0000-0003-4655-0641, Lortholary, Olivier, Morrison, Vicki A., Oren, Ilana, Selleslag, Dominik, Shoham, Shmuel, Thompson, George R., III, Lee, Misun, Maher, Rochelle M., Schmitt-Hoffmann, Anne-Hortense, Zeiher, Bernhardt and Ullmann, Andrew J.
(2016).
Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial.
Lancet, 387 (10020).
S. 760 - 770.
NEW YORK:
ELSEVIER SCIENCE INC.
ISSN 1474-547X